2. Signaling Pathways
  3. Cytoskeleton
  4. Integrin
  5. αIIbβ3 Isoform

αIIbβ3

 

αIIbβ3 Related Products (5):

Cat. No. Product Name Effect Purity
  • HY-P1189A
    Echistatin TFA
    		Antagonist 98.05%
    Echistatin TFA, the smallest active RGD protein belonging to the family of disintegrins that are derived from snake venoms, is a potent inhibitor of platelet aggregation. Echistatin is a potent inhibitor of bone resorption in culture. Echistatin is a potent antagonist of αIIbβ3, αvβ3 and α5β1.
  • HY-P1189
    Echistatin
    		Antagonist
    Echistatin, the smallest active RGD protein belonging to the family of disintegrins that are derived from snake venoms, is a potent inhibitor of platelet aggregation. Echistatin is a potent inhibitor of bone resorption in culture. Echistatin is a potent antagonist of αIIbβ3, αvβ3 and α5β1.
  • HY-10304
    Orbofiban
    Orbofiban is an orally active platelet GPIIb/IIIa antagonist that inhibits platelet aggregation.
  • HY-10304A
    Orbofiban acetate
    		98.13%
    Orbofiban acetate is an orally active platelet GPIIb/IIIa antagonist that inhibits platelet aggregation.
  • HY-P99560
    Tadocizumab
    		Inhibitor
    Tadocizumab (C4G1; YM-337) is a humanized monoclonal antibody tageting integrin αIIbβ3. Tadocizumab has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research.
Cat. No. Product Name / Synonyms Application Reactivity